Noom vs Remedy Meds
Noom costs $100 less a month, and both sell semaglutide and tirzepatide.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
If you are choosing between Noom and Remedy Meds, the first difference is cost: Noom is $100 a month cheaper at the entry price. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. Noom leads our six-part score, 6.7 to 5.1. One of the two has an FDA warning letter on record, covered below.
Noom vs Remedy Meds price
Noom is the cheaper way in: $199 a month against $299 a month at Remedy Meds. That is $100 less each month (33% lower), or about $1,200 over a year of treatment.
Drug by drug: Semaglutide is cheaper at Noom ($199 a month vs $299 a month); tirzepatide is cheaper at Noom ($349 a month vs $399 a month).
Medications and formats
Both sell semaglutide and tirzepatide.
On format, Noom prices brand-name pens and compounded injections, while Remedy Meds prices compounded injections.
If you want the FDA-approved brand rather than a compounded version, Noom is the only one of the two with a brand-name price.
Where each one treats patients
Neither Noom nor Remedy Meds publishes the states it serves, so enter your state at the very start of each sign-up.
Pricing
Noom
Remedy Meds
What each price covers
Both prices cover the clinician visit.
Noom's price also covers coaching, which Remedy Meds does not claim.
Remedy Meds' price also covers the medication itself and shipping, which Noom does not claim.
Noom is silent on the medication itself, shipping and lab work.
Remedy Meds is silent on lab work and coaching.
That matters most for the drug: unless Noom confirms otherwise, budget for medication on top of its listed price.
Noom
Covered by the monthly price
Medication
Not stated
Clinician visits
In the price
Shipping
Not stated
Lab work
Not stated
Coaching
In the price
Remedy Meds
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Where each one scores higher
Overall, Noom scores 6.7 and Remedy Meds 5.1 out of 10.
Noom is stronger on value (4.4 vs 3.0), user experience (8.0 vs 3.0) and trust & safety (6.5 vs 1.0).
Remedy Meds is stronger on support (7.0 vs 4.0).
Effectiveness and accessibility are within half a point.
Noom
6.7/10
Remedy Meds
5.1/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
The FDA sent Remedy Meds a warning letter dated September 9, 2025 (letter 716830), and it is still open.
Noom has no FDA warning letter on record with us.
Features & Coverage
| Feature | Noom | Remedy Meds |
|---|---|---|
| Starting Price | ✓$199/mo | $299/mo |
| Features | 2 features | ✓3 features |
| States Available | Not disclosed | Not disclosed |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | ✓ Yes | — |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | ✓None | 1 letter |
About Noom
Noom is a behavioral weight loss app. It also prescribes GLP-1 medications through Noom Med.
Read our full Noom review →About Remedy Meds
Remedy Meds sells compounded semaglutide and tirzepatide programs through telehealth.
Read our full Remedy Meds review →Pros & Cons
Noom
What we like
- Semaglutide costs $199 a month, close to the $184 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $349 a month, 72% below the $1249 median for brand-name tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes clinician visits and coaching
- We found no FDA warning letters issued to Noom
Watch-outs
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
Remedy Meds
What we like
- The monthly price includes the medication, clinician visits and shipping
Watch-outs
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- The FDA has issued Remedy Meds a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
Noom wins this one, 6.7 to 5.1, above all for coaching bundled into the price rather than sold separately. It also costs $100 less each month than Remedy Meds.
Choose Noom if…
You want coaching bundled into the price rather than sold separately and an opening price near $199 a month.
Choose Remedy Meds if…
You want broader feature coverage and an opening price near $299 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
HealthRX
Compounded semaglutide at $133/month
From $133/mo
Get started →RNK Health
An oral route if you will not self-inject
From $197/mo
Get started →He & She MD
Starting below a standard dose, with microdose tiers
From $99/mo
Get started →Noom vs Remedy Meds: FAQ
Close alternatives to Noom and Remedy Meds
- Noom vs Hims
- Noom vs Hers
- Noom vs Care Bare Rx
- Noom vs Concierge MD LA
- Remedy Meds vs Willow
- Remedy Meds vs Apex MD
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.